FDA backs changing Covid booster shots to target most recent omicron subvariants

There hasn’t been enough research on how much protection a fourth dose can offer, medical professionals told CNBC.
Justin Sullivan | Getty Images

The Food and Drug Administration on Thursday said vaccine manufacturers should update their Covid-19 booster shots to target the most recent omicron subvariants that are gaining ground in the U.S.

Dr. Peter Marks, head of the FDA’s vaccine division, said manufacturers should update their shots to target omicron BA.4 and BA.5 in addition to the original strain of the virus that first emerged in Wuhan, China in 2019.

The FDA’s panel of independent experts voted overwhelmingly on Tuesday to recommend a vaccine switch after an all-day meeting in which they evaluated the benefits and downsides of updating the shots.

This is breaking news. Please check back for updates.

Leave a Reply

Your email address will not be published. Required fields are marked *